1. Home
  2. GSM vs MNMD Comparison

GSM vs MNMD Comparison

Compare GSM & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSM
  • MNMD
  • Stock Information
  • Founded
  • GSM 2015
  • MNMD 2019
  • Country
  • GSM United Kingdom
  • MNMD United States
  • Employees
  • GSM 3283
  • MNMD N/A
  • Industry
  • GSM Metal Mining
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • GSM Basic Materials
  • MNMD Health Care
  • Exchange
  • GSM Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • GSM 780.1M
  • MNMD 709.9M
  • IPO Year
  • GSM N/A
  • MNMD N/A
  • Fundamental
  • Price
  • GSM $4.22
  • MNMD $9.64
  • Analyst Decision
  • GSM Hold
  • MNMD Strong Buy
  • Analyst Count
  • GSM 1
  • MNMD 7
  • Target Price
  • GSM N/A
  • MNMD $24.71
  • AVG Volume (30 Days)
  • GSM 866.0K
  • MNMD 1.1M
  • Earning Date
  • GSM 11-05-2025
  • MNMD 11-06-2025
  • Dividend Yield
  • GSM 1.31%
  • MNMD N/A
  • EPS Growth
  • GSM N/A
  • MNMD N/A
  • EPS
  • GSM N/A
  • MNMD N/A
  • Revenue
  • GSM $1,495,078,000.00
  • MNMD N/A
  • Revenue This Year
  • GSM N/A
  • MNMD N/A
  • Revenue Next Year
  • GSM $18.61
  • MNMD N/A
  • P/E Ratio
  • GSM N/A
  • MNMD N/A
  • Revenue Growth
  • GSM N/A
  • MNMD N/A
  • 52 Week Low
  • GSM $2.97
  • MNMD $4.70
  • 52 Week High
  • GSM $5.12
  • MNMD $11.02
  • Technical
  • Relative Strength Index (RSI)
  • GSM 50.07
  • MNMD 53.20
  • Support Level
  • GSM $4.14
  • MNMD $8.70
  • Resistance Level
  • GSM $4.29
  • MNMD $9.95
  • Average True Range (ATR)
  • GSM 0.12
  • MNMD 0.55
  • MACD
  • GSM 0.00
  • MNMD -0.02
  • Stochastic Oscillator
  • GSM 44.12
  • MNMD 40.52

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: